ArticleScientific reports2016

Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model.

Kefei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.